Gene · 4841
NIH grants1,250
NIH grants whose papers are about the gene, through NIH's grant-paper links.
281 to 300 of 1,250
Download this page as JSON| Grant | Title | NONO papers | Newest fiscal year |
|---|---|---|---|
| R01AG066707 | Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease | 1 | 2024 |
| R01AI114362 | Transcriptional regulatory mechanisms shaping HIV proviral fate | 1 | 2024 |
| R01AI141448 | Cell Intrinsic Immune Control of KSHV | 1 | 2024 |
| R01AI152517 | Signal relay during directed cell migration | 1 | 2024 |
| R01AI153040 | Mechanism and Fidelity of RAG mediated DNA recombination | 1 | 2024 |
| R01AI155319 | Lung immune function in human TB infection and its perturbation by HIV-1. | 1 | 2024 |
| R01AR065538 | Ly6 family members in neutrophil biology | 1 | 2024 |
| R01CA030488 | Mechanisms of Silencing of Retroviral DNAs in Embryonic Cell Lines | 1 | 2024 |
| R01CA077816 | Signal Transduction of Type 1 Interferons in Malignant Cells | 1 | 2024 |
| R01CA138804 | Role of PALB2 in the DNA Damage Response and Cancer Suppression | 1 | 2024 |
| R01CA172408 | Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies | 1 | 2024 |
| R01CA190394 | Targeting the cytokine circuitry of KRAS-driven lung cancer | 1 | 2024 |
| R01CA193318 | Damaged RNA as a mediator of alkylation responses | 1 | 2024 |
| R01CA193481 | Sequence-specific Hybridization Capture for Discovery of Proteoform–lncRNA Interactions in Prostate Cancer | 1 | 2024 |
| R01CA201402 | The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancers | 1 | 2024 |
| R01CA244993 | Novel Targeted Combinatorial Therapy for Hepatocellular Carcinoma | 1 | 2024 |
| R01CA250051 | (PQ#2) Transposable element-mediated gene regulation in KSHV-associated cancer | 1 | 2024 |
| R01DK127738 | Regulation of Ribosome Biogenesis in Hematopoietic Stem Cells | 1 | 2024 |
| R01EY012021 | Mechanisms of Retinal Vascular Permeability in Diabetes | 1 | 2024 |
| R01EY021505 | Post transcriptional control of gene expression in the lens | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4841/grants?page=15